These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33662643)

  • 1. Policy actors and human and animal health practitioners' perceptions of antimicrobial use and resistance in Tanzania: A qualitative study.
    Frumence G; Mboera LEG; Katale BZ; Sindato C; Kimera S; Durrance-Bagale A; Mshana SE; Clark TG; Rweyemamu MM; Legido-Quigley H; Matee M
    J Glob Antimicrob Resist; 2021 Jun; 25():40-47. PubMed ID: 33662643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.
    Frumence G; Mboera LEG; Sindato C; Katale BZ; Kimera S; Metta E; Durrance-Bagale A; Jung AS; Mshana SE; Clark TG; Rweyemamu M; Legido-Quigley H; Matee MIN
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33803077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Implementation of Antimicrobial Resistance Surveillance and Antimicrobial Stewardship Programs in Tanzanian Health Facilities a Year After Launch of the National Action Plan.
    Sangeda RZ; Kibona J; Munishi C; Arabi F; Manyanga VP; Mwambete KD; Horumpende PG
    Front Public Health; 2020; 8():454. PubMed ID: 32974264
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.
    Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E;
    BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of the factors impacting implementation of the national action plan to contain antimicrobial resistance (2016-2020) in medical institutions.
    Tao Y; Wang Y; Zhang Y; Han Y; Feng J; Cheng H; Lin L
    BMC Health Serv Res; 2024 Jan; 24(1):120. PubMed ID: 38254103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.
    Lota MMM; Chua AQ; Azupardo K; Lumangaya C; Reyes KAV; Villanueva SYAM; Legido-Quigley H; Roxas EA
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis.
    Rogers Van Katwyk S; Grimshaw JM; Mendelson M; Taljaard M; Hoffman SJ
    Syst Rev; 2017 Dec; 6(1):256. PubMed ID: 29237496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of investigating antimicrobial resistance in Vietnam - what benefits does a One Health approach offer the animal and human health sectors?
    Mitchell MEV; Alders R; Unger F; Nguyen-Viet H; Le TTH; Toribio JA
    BMC Public Health; 2020 Feb; 20(1):213. PubMed ID: 32046713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.
    Saleem Z; Godman B; Azhar F; Kalungia AC; Fadare J; Opanga S; Markovic-Pekovic V; Hoxha I; Saeed A; Al-Gethamy M; Haseeb A; Salman M; Khan AA; Nadeem MU; Rehman IU; Qamar MU; Amir A; Ikram A; Hassali MA
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):71-93. PubMed ID: 34038294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes.
    Koduah A; Gyansa-Lutterodt M; Hedidor GK; Sekyi-Brown R; Asiedu-Danso M; Asare BA; Ackon AA; Annan EA
    One Health Outlook; 2021 Oct; 3(1):18. PubMed ID: 34663477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Implementation of National Action Plan (NAP) on Antimicrobial Resistance (AMR) in Bangladesh: Challenges and Lessons Learned from a Cross-Sectional Qualitative Study.
    Ahmed SM; Naher N; Tune SNBK; Islam BZ
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of antimicrobial resistance in human health in Tanzania: 2016-2021.
    Camara N; Moremi N; Mghamba J; Eliakimu E; Shumba E; Ondoa P; Egyir B
    Afr J Lab Med; 2023; 12(1):2053. PubMed ID: 37293314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy.
    Busani L; Creti R; Fabbro E; Prestinaci F; Pantosti A; Marella AM; Brusaferro S; Sabbatucci M
    Chemotherapy; 2024; 69(1):56-64. PubMed ID: 37673044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.
    Chan OSK; Wernli D; Liu P; Tun HM; Fukuda K; Lam W; Xiao Y; Zhou X; Grépin KA
    Health Policy Plan; 2022 Oct; 37(9):1148-1157. PubMed ID: 35775460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: A roadmap for action.
    Iwu CD; Patrick SM
    Int J Antimicrob Agents; 2021 Oct; 58(4):106411. PubMed ID: 34371112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring medical and veterinary student perceptions and communication preferences related to antimicrobial resistance in Ontario, Canada using qualitative methods.
    Primeau CA; McWhirter JE; Carson C; McEwen SA; Parmley EJ
    BMC Public Health; 2023 Mar; 23(1):483. PubMed ID: 36915074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling antimicrobial resistance in Bangladesh: A scoping review of policy and practice in human, animal and environment sectors.
    Hoque R; Ahmed SM; Naher N; Islam MA; Rousham EK; Islam BZ; Hassan S
    PLoS One; 2020; 15(1):e0227947. PubMed ID: 31986167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to move towards One Health surveillance? A qualitative study exploring the factors influencing collaborations between antimicrobial resistance surveillance programmes in France.
    Bourély C; Rousset L; Colomb-Cotinat M; Collineau L
    Front Public Health; 2023; 11():1123189. PubMed ID: 37497029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions.
    Sommanustweechai A; Tangcharoensathien V; Malathum K; Sumpradit N; Kiatying-Angsulee N; Janejai N; Jaroenpoj S
    Public Health; 2018 Apr; 157():142-146. PubMed ID: 29524812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.